Mantle cell lymphoma epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
The incidence of mantle cell lymphoma was estimated to be 3-10% of non-hodgkins lymphoma. | |||
===Prevalence=== | ===Prevalence=== | ||
There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.) | There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.) |
Revision as of 18:57, 31 August 2015
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma epidemiology and demographics |
Mantle cell lymphoma epidemiology and demographics in the news |
Risk calculators and risk factors for Mantle cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Mantle cell lymphoma is a rare disease that tends to affect elderly patients > 60 years. Male are more commonly affected with mantle cell lymphoma than female. The male to female ratio is approximately 4 to 1.
Epidemiology and Demographics
Incidence
The incidence of mantle cell lymphoma was estimated to be 3-10% of non-hodgkins lymphoma.
Prevalence
There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.)
Age
Mantle cell lymphoma is a rare disease that tends to affect elderly patients > 60 years.
Gender
Male are more commonly affected with mantle cell lymphoma than female. The male to female ratio is approximately 4 to 1.